GL1X · GenesisL1 explorer

Research workbench

Non-receptor protein tyrosine phosphatase SHP2 in complex with allosteric inhibitor SHP836

Analyse Non-receptor protein tyrosine phosphatase SHP2 in complex with allosteric… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5EHP
Type
protein
Length
965 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein phosphatase non-receptor type 11
EC
3.1.3.48
UniProt
Q06124
Ligands
5OA, PO4
Pockets
13 · best druggability 0.68

Structure

x-ray diffraction · 2 distinct chains · 31% helix, 27% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48)protein49431% helix, 27% strandQ06124
BTyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48)protein47132% helix, 28% strandQ06124

Ligands and binding sites

  • 5OA · 5-[2,3-bis(chloranyl)phenyl]-2-[(3~{R},5~{S})-3,5-dimethylpiperazin-1-yl]pyrimidin-4-amine · ligand · 2 copies · chains A, B
  • PO4 · Phosphate ion · ion · 8 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

13 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18200.680.7568empty
24190.660.79355OA
34400.650.78365OA
41840.570.8027empty
51560.550.8120PO4

Interfaces

1 interface between chains.

  • A–B · 185 Ų buried · 2 hydrogen bonds · protein-protein

Compared structures

  • 5EHP · Non-receptor Protein Tyrosine Phosphatase SHP2 in Complex with Allosteric Inhibitor SHP836 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.